Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?
作者信息
Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A
机构信息
UO Dermatologia Lucca- Azienda USL Toscana Nordovest, Lucca, Italy.
Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
Abstract
摘要
相似文献
1
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?BNT162b2 mRNA新冠疫苗接种后眼睑出现紫癜性病变：SARS-CoV-2皮肤谜题的又一拼图？
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
2
Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.BNT162B2 mRNA新冠疫苗接种后出现色素性紫癜性皮病
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
3
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.BNT162b2信使核糖核酸新冠疫苗诱发的冻疮样损伤强化了其与严重急性呼吸综合征冠状病毒2关系的假说。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
4
Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗注射部位的皮肤溃疡
J Dermatol. 2021 Dec;48(12):e596-e597. doi: 10.1111/1346-8138.16163. Epub 2021 Sep 21.
5
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗的皮肤反应
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
6
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
7
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.6个月后对BNT162b2 mRNA新冠疫苗抗体反应的动态变化
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.
8
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?BNT162B2 mRNA新冠疫苗在心肺移植年轻成年人中的应用：是否需要另一种严重急性呼吸综合征冠状病毒2免疫反应监测方法？
Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.
9
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.BNT162b2 mRNA新冠疫苗接种后发生的嗜酸性粒细胞性蜂窝织炎
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.
10
Safety and BNT162b2 mRNA COVID-19 vaccination.安全性和 BNT162b2 mRNA COVID-19 疫苗接种。
Acta Biomed. 2022 Jan 19;92(6):e2021485. doi: 10.23750/abm.v92i6.12359.
引用本文的文献
1
COVID and COVID vaccine-related corneal morbidity: A review.COVID 及与 COVID 疫苗相关的角膜发病机制：综述。
Indian J Ophthalmol. 2023 Dec 1;71(12):3595-3599. doi: 10.4103/IJO.IJO_765_23. Epub 2023 Nov 20.
2
Lower Eyelid Complication After Blepharoplasty and COVID-19 Vaccination.双眼皮手术后与接种 COVID-19 疫苗后的下眼睑并发症。
Aesthetic Plast Surg. 2023 Dec;47(6):2573-2578. doi: 10.1007/s00266-023-03532-7. Epub 2023 Aug 14.
3
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?新冠疫苗会引发过早的非传染性疾病吗：我们正走向何方？
Vaccines (Basel). 2023 Jan 17;11(2):208. doi: 10.3390/vaccines11020208.
4
Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination: A Case Report and Review of Literature.新型冠状病毒肺炎灭活疫苗接种后单侧急性中心性浆液性脉络膜视网膜病变：一例报告并文献复习
J Curr Ophthalmol. 2022 Nov 30;34(3):373-378. doi: 10.4103/joco.joco_41_22. eCollection 2022 Jul-Sep.
5
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?新型冠状病毒2型疫苗接种与冻疮样病变：我们目前了解到了什么？
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
6
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.辉瑞-生物科技（BNT162b2）、莫德纳（mRNA-1273）COVID-19 mRNA 疫苗与过敏反应。
J Natl Med Assoc. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. Epub 2022 Oct 28.
7
Ocular adverse effects of COVID-19 vaccines: A systematic review.新冠疫苗的眼部不良反应：一项系统综述。
J Family Med Prim Care. 2022 Sep;11(9):5041-5054. doi: 10.4103/jfmpc.jfmpc_747_22. Epub 2022 Oct 14.
8
Evaluation of the Effect of İnfection and İmmunity on the Tear Film by Scheimpflug-Placido Disc Topography- A Case Control Study.评价感染和免疫对泪膜的影响的 Scheimpflug-Placido 盘地形图分析：一项病例对照研究。
Photodiagnosis Photodyn Ther. 2023 Mar;41:103216. doi: 10.1016/j.pdpdt.2022.103216. Epub 2022 Dec 5.
9
Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2.病毒感染及相应疫苗引起的眼部效应：水痘带状疱疹病毒、麻疹病毒、流感病毒、乙型肝炎病毒及严重急性呼吸综合征冠状病毒2概述
Front Med (Lausanne). 2022 Oct 26;9:999251. doi: 10.3389/fmed.2022.999251. eCollection 2022.
10
COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview.2019冠状病毒病疫苗相关眼部不良反应概述
Vaccines (Basel). 2022 Nov 7;10(11):1879. doi: 10.3390/vaccines10111879.
本文引用的文献
1
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
2
Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series.辉瑞-生物科技公司新冠疫苗接种后的短暂皮肤表现：一项意大利单中心病例系列研究
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e483-e485. doi: 10.1111/jdv.17268. Epub 2021 Apr 24.
3
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.过敏性皮肤病患者接种新型冠状病毒肺炎疫苗后发生严重过敏反应的风险——实用建议。欧洲皮肤科和性病学会与外部专家的立场声明
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.
4
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
5
Chilblain-like lesions and COVID-19: second wave, second outbreak.冻疮样病变与新型冠状病毒肺炎：第二波，第二次爆发。
J Eur Acad Dermatol Venereol. 2021 May;35(5):e316-e318. doi: 10.1111/jdv.17145. Epub 2021 Mar 2.
6
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.COVID-19 大流行期间冻疮样皮损患者的临床、实验室和干扰素-α反应特征。
JAMA Dermatol. 2021 Feb 1;157(2):202-206. doi: 10.1001/jamadermatol.2020.4324.
7
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.新冠疫情期间冻疮样皮损的皮肤镜检查：一项针对10例患者的多中心研究
J Am Acad Dermatol. 2020 Dec;83(6):1749-1751. doi: 10.1016/j.jaad.2020.07.058. Epub 2020 Sep 30.
8
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
9
Chilblain-like lesions during the COVID-19 pandemic: should we really worry?新冠疫情期间的冻疮样病变：我们真的需要担心吗？
Int J Dermatol. 2020 Aug;59(8):1026-1027. doi: 10.1111/ijd.14993. Epub 2020 Jun 4.
10
Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions.新型冠状病毒肺炎疫情期间的肢端表现：冻疮样病变较肢端缺血性病变更为常见。
J Am Acad Dermatol. 2020 Sep;83(3):e231. doi: 10.1016/j.jaad.2020.05.077. Epub 2020 May 22.
Zotero 插件